Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE (Details Narrative)

v2.4.0.6
NOTES PAYABLE (Details Narrative) (USD $)
 9 Months Ended 57 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2012
Financing Arrangement Directors and Officers Insurance
Jun. 30, 2012
Financing Arrangement Clinical Trial Insurance
Notes payable, amount $ 500,000   $ 500,000 $ 48,300 $ 11,843
Notes payable, interest rate       11.50% 12.95%
Principal repaid       30,383  
Interest Paid $ 906 $ 2,374 $ 70,829 $ 1,667  
Issuance date       Mar. 24, 2012 Jun. 30, 2012